Dong Sung Bio Pharm.Co.,Ltd.
Símbolo: 002210.KS
KSC
5240
KRWPrecio de mercado actual
-57.7739
Ratio PER
-0.8344
Ratio PEG
119.82B
Capitalización MRK
- 0.00%
Rendimiento DIV
Dong Sung Bio Pharm.Co.,Ltd. (002210-KS) Estados Financieros
Balance de situación
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 21733.89 | 6435.4 | 4093.8 | 5142.8 | |||||||||||||||||
balance-sheet.row.short-term-investments | -3073.9 | 0 | 0 | 2002.6 | |||||||||||||||||
balance-sheet.row.net-receivables | 127499.54 | 31290.9 | 35361.6 | 29324.5 | |||||||||||||||||
balance-sheet.row.inventory | 72346.52 | 19477.1 | 14933.8 | 15519.1 | |||||||||||||||||
balance-sheet.row.other-current-assets | 16601.77 | 3611.5 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-current-assets | 238181.72 | 60814.9 | 54389.2 | 49986.3 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 172690.32 | 42725.5 | 43960.4 | 37377.8 | |||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.intangible-assets | 3645.02 | 978.8 | 855.8 | 942.7 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 3645.02 | 978.8 | 855.8 | 942.7 | |||||||||||||||||
balance-sheet.row.long-term-investments | 12525.06 | 7719.6 | 510.2 | -1606.9 | |||||||||||||||||
balance-sheet.row.tax-assets | 11078.52 | 0 | -510.2 | 17882 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 18636.95 | 2734.6 | 8496.6 | 0 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 218575.87 | 54158.4 | 53312.9 | 54595.6 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 456757.59 | 114973.3 | 107702.1 | 104581.9 | |||||||||||||||||
balance-sheet.row.account-payables | 47580.16 | 11261.1 | 8852 | 6858.8 | |||||||||||||||||
balance-sheet.row.short-term-debt | 112670.19 | 24732.5 | 29274 | 19714 | |||||||||||||||||
balance-sheet.row.tax-payables | 66.53 | 0 | 418.8 | 262.1 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 52132.34 | 18522.4 | 7761.9 | 9600.8 | |||||||||||||||||
Deferred Revenue Non Current | 17174.11 | 17.9 | 0 | 9113.3 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 10739.73 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 60212.7 | 8850.2 | 9183.7 | 3729.5 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 95537.15 | 30327.1 | 17321.6 | 20552.3 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 231.81 | 17.9 | 104.1 | 55.7 | |||||||||||||||||
balance-sheet.row.total-liab | 289693.7 | 75171 | 64892.8 | 58141.5 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 104403.88 | 26101 | 26101 | 26101 | |||||||||||||||||
balance-sheet.row.retained-earnings | 4190.1 | -3006.9 | 1153.1 | -2570.8 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 11151.02 | 2787.8 | 2787.8 | 2787.8 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 47318.89 | 13920.5 | 12767.5 | 20122.4 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 167063.89 | 39802.3 | 42809.3 | 46440.4 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 456757.59 | 114973.3 | 107702.1 | 104581.9 | |||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-equity | 167063.89 | 39802.3 | 42809.3 | 46440.4 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 456757.59 | - | - | - | |||||||||||||||||
Total Investments | 9451.15 | 7719.6 | 510.2 | 395.7 | |||||||||||||||||
balance-sheet.row.total-debt | 164820.39 | 43272.8 | 37035.8 | 29314.8 | |||||||||||||||||
balance-sheet.row.net-debt | 147179.16 | 36837.4 | 32942 | 26174.6 |
Estado de tesorería
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -2073.91 | -2073.9 | -2121.7 | -4312.8 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 2082.09 | 2046 | 2119.7 | 2222.6 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.change-in-working-capital | -5165.38 | -5165.4 | -4348.3 | -2543.3 | |||||||||||||||||
cash-flows.row.account-receivables | 2887.7 | 2887.7 | -4280.9 | -1791.5 | |||||||||||||||||
cash-flows.row.inventory | -3965.32 | -3965.3 | 629.7 | 4466.7 | |||||||||||||||||
cash-flows.row.account-payables | 1519.79 | 1519.8 | 1995 | -2870.6 | |||||||||||||||||
cash-flows.row.other-working-capital | -5607.55 | -5607.6 | -2692.1 | -2348 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 863.87 | 900 | 467.6 | 1882 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -4293.33 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -923.56 | -923.6 | -642.9 | -2323.5 | |||||||||||||||||
cash-flows.row.acquisitions-net | 32.78 | 18.2 | 74.3 | -197.7 | |||||||||||||||||
cash-flows.row.purchases-of-investments | -48.49 | -57.5 | -56.2 | -10994.9 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | -32.78 | 0 | 2019.9 | 14989.6 | |||||||||||||||||
cash-flows.row.other-investing-activites | 44.34 | 35.2 | -756.9 | -11173.2 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -927.71 | -927.7 | 638.3 | -9699.8 | |||||||||||||||||
cash-flows.row.debt-repayment | -33936.52 | -1229.6 | -44052.3 | -26435.5 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 8455.4 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -1996.4 | -2990.4 | |||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | -8455.4 | |||||||||||||||||
cash-flows.row.other-financing-activites | 41503.88 | 8797 | 50289 | 30657.7 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 7567.35 | 7567.4 | 4240.2 | 1231.8 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -4.71 | -4.7 | -42.3 | 7.6 | |||||||||||||||||
cash-flows.row.net-change-in-cash | 2341.6 | 2341.6 | 953.6 | -11211.9 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 17641.23 | 6435.4 | 4093.8 | 3140.2 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 15299.63 | 4093.8 | 3140.2 | 14352.1 | |||||||||||||||||
cash-flows.row.operating-cash-flow | -4293.33 | -4293.3 | -3882.6 | -2751.5 | |||||||||||||||||
cash-flows.row.capital-expenditure | -923.56 | -923.6 | -642.9 | -2323.5 | |||||||||||||||||
cash-flows.row.free-cash-flow | -5216.9 | -5216.9 | -4525.5 | -5075.1 |
Fila de la Cuenta de Resultados
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 88593.59 | 88593.6 | 93328.2 | 84407.7 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 47447.64 | 47943.9 | 51272.8 | 50864 | |||||||||||||||||
income-statement-row.row.gross-profit | 41145.95 | 40649.6 | 42055.4 | 33543.6 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 4169.12 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 12376.07 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 24762.64 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | -20425.25 | -221 | 12200 | 12364.1 | |||||||||||||||||
income-statement-row.row.operating-expenses | 18666 | 40053.2 | 45152.4 | 38842.7 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 77055.41 | 87997.2 | 96425.2 | 89706.7 | |||||||||||||||||
income-statement-row.row.interest-income | 63.26 | 63.3 | 47.1 | 76.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 2240.91 | 2240.9 | 1307.8 | 712.2 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 24762.64 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -1462.29 | -1462.3 | 191.2 | 919.7 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | -20425.25 | -221 | 12200 | 12364.1 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | -1462.29 | -1462.3 | 191.2 | 919.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 2240.91 | 2240.9 | 1307.8 | 712.2 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 12820.26 | 2046 | 2119.7 | 3980.6 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 13416.67 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | 596.4 | 596.4 | -2041.8 | -5299 | |||||||||||||||||
income-statement-row.row.income-before-tax | -865.89 | -865.9 | -1850.6 | -4379.3 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 1208.02 | 1208 | 271.1 | -66.5 | |||||||||||||||||
income-statement-row.row.net-income | -2073.91 | -2073.9 | -2121.7 | -4312.8 |
Preguntas frecuentes
Cuánto es Dong Sung Bio Pharm.Co.,Ltd. (002210.KS) activos totales?
Dong Sung Bio Pharm.Co.,Ltd. (002210.KS) los activos totales son 114973284037.000.
¿Cuáles son los ingresos anuales de la empresa?
Los ingresos anuales son 43786401591.000.
¿Cuál es el margen de beneficios de la empresa?
El margen de beneficios de la empresa es 0.464.
¿Qué es el flujo de caja libre de la empresa?
El flujo de caja libre es -228.151.
¿Cuál es el margen de beneficio neto de la empresa?
El margen de beneficio neto es -0.023.
¿Cuáles son los ingresos totales de la empresa?
Los ingresos totales son 0.007.
¿Qué es Dong Sung Bio Pharm.Co.,Ltd. (002210.KS) beneficio neto (ingresos netos)?
El beneficio neto (ingresos netos) es -2073909512.000.
¿Cuál es la deuda total de la empresa?
La deuda total es 43272811605.000.
¿Cuál es la cifra de gastos de explotación?
Los gastos de explotación son 40053242263.000.
¿Cuál es la cifra de tesorería de la empresa?
La tesorería de la empresa es 6435381432.000.